Sunshine Holdings Plc · CSELK:SUN.N0000
Sunshine — Q3 FY2026 Earnings Presentation
39 slides from Sunshine's earnings presentation, Feb 12, 2026
Slide 1: 3QFY26 Earnings Webinar
3QFY26 Earnings Webinar Sunshine Holdings PLC 12 February 2026
Slide 2: Housekeeping Announcements
Housekeeping Announcements • The webinar will be recorded and later uploaded to our IR website as well as CSE website for future reference (https://www.sunshineholdings.lk/investor-relations/) • All participants will be muted during the presentation • Participants can use the 'Raise Hand' option to
Slide 3: Team
Team Sunshine Holdings Sunshine Healthcare Shantha Bandara Dr. Thiru Sayandhan Farman Nizar Eranga Illangasinghe CEO - Sunshine Pharmaceuticals CEO - Sunshine Medical Devices COO - Healthguard Pharmacy Sector Financial Controller - and Healthguard Distribution and Lina Manufacturing Healthcare Shyam
Slide 4: Corporate Announcements
Corporate Announcements • 21st January 2026 – Sunshine Holdings PLC entered into a share sale and purchase agreement to acquire 577,320 shares of Joint Agri Products Ceylon (Private) Limited (JAPC) for LKR 2.7bn, resulting in an effective 75% stake post-restructuring, expanding its Consumer sector p
Slide 5: Group Performance
Group Performance
Slide 6: Group at a glance – 3QFY26
Group at a glance – 3QFY26 Revenue Composition - 3QFY26 LKR 2.0bn LKR 1.3bn LKR 0.43 Agriculture -28.1% YoY -26.6% YoY -28.3% YoY 17.6% 12.5% EBIT Earnings EPS LKR 16.6bn 24.1% 17.0% LKR 10.24 3.0 pts YoY -3.1 pts YoY -0.1% YoY 28.6% 9.5% Gearing ROE NBV 58.9% Healthcare Consumer 12.8% 2.3% LKR 69.1
Slide 7: Key ratios – 9MFY26
Key ratios – 9MFY26 INVESTOR RATIOS PROFITABILITY RATIOS 9MFY26 9MFY25 9MFY26 9MFY25 LKR 1.74 LKR 1.97 30.3% 30.8% EPS TTM EPS TTM 17.04% 20.13% GP Margin GP Margin ROE ROE 15.3% 16.4% 20.11 12.71 EBIT Margin EBIT Margin PER TTM PER TTM 10.24 10.25 NAV NAV 8.7% 10.4% 3.43 2.44 PAT Margin PAT Margin
Slide 8: Group – Performance Highlights
Group – Performance Highlights LKR m 3QFY26 3QFY25 YoY % 2QFY26 QoQ % Revenue 16,568 15,134 9.5% 16,396 1.0% EBIT 1,986 2,761 -28.1% 2,846 -30.2% EBIT margin 12.0% 18.2% 17.4% PAT 1,291 1,759 -26.6% 1,320 -2.2% PAT margin 7.8% 11.6% 8.1% EPS (LKR) 0.43 0.61 -28.3% 0.35 23.0% • Lower Healthcare contr
Slide 9: Movement in Revenue & EBIT
Movement in Revenue & EBIT Revenue Movement [LKR Million] EBIT Movement [LKR Million] 1,107 108 311 16,568 2,761 15,134 (91) 17 35 1,986 (747) (80) 3QFY25 Healthcare Consumer Agri Other 3QFY26 3QFY25 Healthcare Consumer Agri Other 3QFY26 Revenue Composition – Revenue QoQ 18.0 16.0 13% 14% 16% 16% 14
Slide 10: Healthcare
Healthcare
Slide 11: Sunshine Healthcare Lanka overview
Sunshine Healthcare Lanka (SHL) is Sri Lanka’s only fully integrated healthcare company encompassing the entire pharma value chain Government and Local market Manufacturing and R&D Revenue Split 3QFY26 Sri Lanka’s first facility for Respiratory Care Manufacturing Capsules Tablets Nasal Spray Devices
Slide 12: Healthcare Sector – Highlights
Healthcare Sector – Highlights Sector Highlights 8,650 9,757 8,619 8,714 7,804 Healthcare sector revenue grew 12.8% YoY in 3QFY26, driven by sustained momentum across the agency, distribution, and retail businesses However, the sector’s overall profitability was impacted by the slowdown in the manuf
Slide 13: Sunshine Pharmaceuticals – Performance Highlights
Sunshine Pharmaceuticals – Performance Highlights Business Highlights 8,877 The pharmaceutical segment’s revenue grew by 17.3% YoY in 3QFY26, driven by continued growth in existing agencies. 5,137 4,609 4,730 4,033 The RD segment grew 6.5% YoY during the 9MFY26 (Volume growth of 7.8% YoY), underscor
Slide 14: Healthguard Distribution – Performance Highlights
Healthguard Distribution – Performance Highlights Business Highlights 5,969 5,869 5,894 The Distribution segment’s revenue grew by 16.4% YoY in 3QFY26, 5,130 5,177 driven by a significant volume increase of 16.8% YoY during the quarter This volume growth was supported by contributions from both exis
Slide 15: Sunshine Medical Devices – Performance Highlights
Sunshine Medical Devices – Performance Highlights Business Highlights 1,437 1,453 1,251 1,237 1,151 The Medical Devices segment recorded a 1.1% YoY revenue growth in 3QFY26, reflecting moderate performance, with stronger growth in the private segment partially offset by softness in the government se
Slide 16: Lina Manufacturing – Performance Highlights
Lina Manufacturing – Performance Highlights Business Highlights 1,459 1,174 During 3QFY26, revenue from the manufacturing business declined by 19.5% YoY, primarily due to the reduction in government 906 931 purchase orders for the 2025 calendar year 437 Lina has been awarded the government MDI order
Slide 17: Healthguard Pharmacy – Performance Highlights
Healthguard Pharmacy – Performance Highlights Business Highlights 762 752 The Retail segment, Healthguard Pharmacy, recorded a 9.9% YoY 735 increase in revenue for 3QFY26, driven by volume and value growth 713 across both pharmaceutical and wellness ranges 694 3QFY25 4QFY25 1QFY26 2QFY26 3QFY26 Reve
Slide 18: Consumer Brands
Consumer Brands
Slide 19: Sunshine Consumer Brands overview
Sunshine Consumer Brands, market leader in branded tea and confectionery Brand Portfolio Revenue Split 3QFY26 Tea Inter Co. / Other, Exports, 34% -2% Largest branded tea company in Sri Lanka – 47.9% market share. *Peppercube Retail Measurement Survey Value Share Catering to three distinct need and v
Slide 20: Consumer Brands Sector – Highlights
Consumer Brands Sector – Highlights 4,983 Sector Highlights 4,624 4,781 4,732 4,373 The Consumer Brands sector, including both export and domestic businesses, recorded a revenue improvement of 2.3% YoY in 3QFY26, growth was moderated primarily due to weaker performance in the export segment. Segment
Slide 21: Tea Brands – Performance Highlights
Tea Brands – Performance Highlights 2,725 Business Highlights 2,631 Revenue from the Branded Tea business grew by 11.1% YoY to LKR 2.7 Bn in 3QFY26, driven by strong execution in modern trade and 2,454 2,433 retail channels with focused promotions. 2,276 Our core tea brands, Zesta, Watawala Thei and
Slide 22: Confectionery Brands – Performance Highlights
Confectionery Brands – Performance Highlights 557 Business Highlights 494 529 476 Revenue from the Confectionery business improved significantly by 404 17.9% YoY in 3QFY26 supported by successful relaunch initiatives and wider market coverage. However, the segment quarter-over-quarter, recorded a 14
Slide 23: Exports – Performance Highlights
Exports – Performance Highlights Business Highlights 2,066 The export business recorded a revenue contraction of 12.1% YoY 1,851 1,850 in 3QFY26 to reach LKR 1.6 Bn. 1,532 1,628 This was mainly due to changing of product mix from the value addition range to bulk tea orders. 3QFY25 4QFY25 1QFY26 2QFY
Slide 24: Agribusiness
Agribusiness
Slide 25: Watawala Plantations overview
Watawala Plantations PLC primarily engages in palm oil and dairy farming Palm Oil Revenue Split 3QFY26 A land extent of ~3,400 Ha under palm oil cultivation Diary, 13% The first in South Asia to receive RSPO certification for sustainable oil palm plantation Positioning – largest oil palm cultivator
Slide 26: Agribusiness – Highlights
Agribusiness – Highlights Sector Highlights 2,698 2,492 The Agribusiness sector reported revenue of LKR 2.1 Bn in 3QFY26, reflecting a 17.6% YoY improvement, driven by the 2,078 1,767 1,919 performance of the palm oil business. 1,329 1,216 Business seasonality is high crop in Q1 and Q2. 750 767 588
Slide 27: Palm Oil – Performance Highlights
Palm Oil – Performance Highlights 2,398 Business Highlights 2,213 The Palm Oil segment recorded a 23.6% YoY improvement in 1,813 revenue in 3QFY26, driven by both volume growth and favorable 1,652 Net Sales Averages for CPO and KPO. 1,468 1,385 1,231 830 648 764 3QFY25 4QFY25 1QFY26 2QFY26 3QFY26 EB
Slide 28: Dairy – Performance Highlights
Dairy – Performance Highlights Business Highlights 299 300 279 The dairy business recorded a 11.6% YoY contraction in revenue in 267 265 3QFY26, mainly driven by decrease in milk sales volumes during the quarter. 38 (15) (44) (40) (63) 3QFY25 4QFY25 1QFY26 2QFY26 3QFY26 EBIT (LKR Mn) Revenue (LKR Mn
Slide 29: Q&A
Q&A
Slide 30: Appendix
Appendix
Slide 31: Proposed Acquisition - Joint Agri Products Ceylon (Private) Limited
Proposed Acquisition - Joint Agri Products Ceylon (Private) Limited 30+ USD 20mn 25+ Years of experience Revenue Worldwide Markets Acquisition of 75% controlling interest 350+ 6,000+ 2.9mn kg Employees Farmers’ network Processed Largest organic spice exporter with 30+ year 100,000+ sq. ft Ceylon Cin
Slide 32: Sunshine Pharmaceuticals – Market Dynamics
Sunshine Pharmaceuticals – Market Dynamics During 3Q IQVIA, the market experienced a growth of 9.3% (2025 MAT%) 13.0% 12.8% 64.8% 10.4% 10.3% 10.3% 26.7% 17.5% 16.9% 17.3% 14.3% 12.0% 10.5% 9.3% 7.6% 7.3% 5.1% 3.0% 2.2% 1.2% 3QFY25 4QFY25 1QFY26 2QFY26 3QFY26 SHP Value Growth YoY SHP Volume growth Y
Slide 33: Sunshine Medical Devices – Market Dynamics
Sunshine Medical Devices – Market Dynamics 89% 88% 88% 86% 86% 85% 84% 81% 81% 82% 81% 80% 77% 79% 79% 77% 77% 76% 75% 73% 70% 1QFY25 2QFY25 3QFY25 4QFY25 1QFY26 2QFY26 3QFY26 Hospital Occupancy Lab Tests Operation Theaters Source – Management Information
Slide 34: Brand Value Market Share (%) – Tea
Brand Value Market Share (%) – Tea 100.0 90.0 23 26 26 28 28 27 27 27 28 28 27 27 29 29 28 28 29 28 29 29 28 32 30 29 31 80.0 8 70.0 9 9 6 6 6 5 5 5 5 5 5 5 5 5 8 7 6 5 4 5 5 6 6 7 60.0 50.0 46 45 45 47 47 48 49 49 49 48 48 48 47 48 45 46 44 45 48 48 47 50 48 49 47 40.0 30.0 20.0 10.0 23 21 20 20 19
Slide 35: Brand Value Market Share (%) – Confectionary
Brand Value Market Share (%) – Confectionary 100.0 90.0 23 23 23 24 24 24 25 25 25 26 25 24 80.0 70.0 16.3 15.4 14.7 14.4 13.3 13.7 17.7 17.6 14.5 15.1 14.2 13.0 60.0 50.0 35.1 36.7 35.6 37.2 37.1 35.6 36.4 36.1 36.4 36.2 40.0 34.9 34.3 30.0 20.0 24.0 23.9 25.5 24.8 25.4 24.4 23.8 24.6 24.7 25.0 25.
Slide 36: Price Index – Tea and Confectionary
Price Index – Tea and Confectionary Confectionery Price Index 125 Tea Price Index 122 210 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 120 117 118 193 193 193 117 190 115 113 111 172 172 172 172 172 110 109 170 166 163 162 162 163164 106 159 160160 159 158 157
Slide 37: Agribusiness – Price Movement
Agribusiness – Price Movement WDL's Avg Milk Price (LKR) Settlement Price (RM) 234 5,500 233 232 5,000 230 229 MALAYSIAN RINGGITS – RM 4,500 228 4,171 226 4,000 3,930 224 3,500 222 3,000 220 2,500 218 December-24 February-25 April-25 June-25 August-25 October-25 December-25 Source - Malaysian contra
Slide 38: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements that are based on management’s current expectations and assumptions. Forward-looking statements include predictions of future results or activities and may contain the words “expects,” “believes,” “should,” “will,” “ant
Slide 39: Thank you!
Thank you! For more information, Please visit our Investor Relations page https://www.sunshineholdings.lk/investor-relations/